ArticleCancer biomarkers : section A of Disease markers2024

PD-1 inhibitor combined with Docetaxel exerts synergistic anti-prostate cancer effect in mice by down-regulating the expression of PI3K/AKT/NFKB-P65/PD-L1 signaling pathway.

Sixu Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.